xpeer logo

© 2026 XPEER MEDED, S.L. · Av. del Portal de l'Àngel, 38, 4º 5ª, 08002 Barcelona, Spain · All rights reserved

Privacy Policy - Terms of Use - Help

Register now for free!

Over 100,000 doctors have already joined Xpeer — register now to find out why, and get instant access to this course and many more.

I already have an account
Course Preview

Ocular adverse events of onco-haematological therapies: recognition and management

5

Accredited (Credits: 1)
Free
42min
Audio: English

Synopsis

The emergence of novel therapies in haemato-oncology has transformed cancer treatment but has also introduced new challenges in recognising and managing ocular adverse events.

This course explores the mechanisms, clinical manifestations and management of ocular toxicities associated with antibody-drug conjugates, targeted therapies and immune checkpoint inhibitors. Through clinical examples, participants will gain insights into the identification and grading of ocular adverse events (AEs), appropriate monitoring strategies and practical approaches to their management.

Emphasis is placed on balancing the preservation of vision and quality of life with the need to maintain effective cancer treatment. The course also addresses challenges in clinical practice in Belgium and highlights the importance of timely communication and multidisciplinary collaboration between ophthalmologists, oncologists and haematologists to optimise patient care.

This activity is supported by an independent support grant from GSK

Objectives

After completing this activity, participants should be better prepared to:

  • Identify common ocular adverse events associated with oncology and haematology treatments
  • Apply best practices for referral, diagnosis, and management
  • Improve multidisciplinary collaboration between ophthalmology and treating specialists

Accreditation

This course is accredited with 1 ECMEC credit valid in 26 countries. To claim your credits take the evaluation (satisfaction survey and evaluation questionnaire). You have 3 attempts for the evaluation. You need to pass the evaluation with a sufficient score to validate the course. Your diploma is issued instantaneously and sent to your email.

See more information on the accreditation at: Accreditation

Duration

42min

Target audience

Oncology, Ophthalmology, Doctor / Physician, Nurse

Authors

Dr. Heleen Delbeke, MD, PhD

Dr. Delbeke is a Consultant Ophthalmologist at UZ Leuven and Assistant Professor at KU Leuven in Leuven, Belgium. She specialises in cornea conditions and refractive surgery.

Conflicts of interests statement:

Nothing to declare.

Testimonials

“Xpeer is a magnificent platform for healthcare professionals, where you can gain knowledge from a scientific and highly up-to-date perspective across various medical specialties.”

Wil A. onTrustpilot

Netherlands

“I've taken several courses on Xpeer and they've been very useful. The format is very dynamic, allowing you to watch the videos in your free time since they're no longer than 15 minutes. The topics are very current.”

Francisco P. onTrustpilot

Spain

“Excellent platform to stay up to date and keep learning throughout your professional career. I recommend it to all my colleagues.”

Omar I. onTrustpilot

Spain

Read more reviews onTrustpilot

FAQs

What you will learn

Before you begin

  • Pre-course assessment: please complete to help us personalise your learning experience

Trailer

  • Trailer

New cancer therapies: implications for ophthalmology

  • Overview
  • Antibody-drug conjugates
  • Targeted therapies
  • Immune checkpoint inhibitors

Management of ocular AEs

  • AE grading
  • AE management
  • Prophylactic approaches
  • Lessons from Belgium
  • Multidisciplinary management and key takeaways

Accreditation - Evaluation

  • Satisfaction survey
  • Multiple-choice test

Register now for free!

Over 100,000 doctors have already joined Xpeer — register now to find out why, and get instant access to this course and many more.

I already have an account